Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats - PubMed (original) (raw)
Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats
Francesca Cicchetti et al. Neurobiol Dis. 2005 Nov.
Abstract
In recent years, several lines of evidence have shown an increase in Parkinson's disease (PD) prevalence in rural environments where pesticides are widely used. Paraquat (PQ--herbicide) and maneb (MB--fungicide) are among the compounds suspected to induce neuronal degeneration and motor deficits characteristics of PD. Here, we investigated the effects of PQ and MB on dopaminergic (DA) neuron-glia cultures and in vivo in young adult rats. In vitro, PQ led to a loss of DA as compared to non-DA neurons and microglial activation in a dose-dependent manner. Addition of MB had no further effect nor did it lead to microglial activation when used alone. In vivo, 2-month old young adult rats were subjected to intraperitoneal injections of vehicle (n = 4), PQ alone (n = 8), or PQ in combination with MB (n = 8) twice a week for 4 weeks and were sacrificed the day following the last injection. Significant loss of nigral DA neurons was observed in both treatment groups, but a significant decrease in striatal DA fibers was not found. Microglial activation was seen in the nigra of rats subjected to PQ with or without MB. Behavioral analyses demonstrated a mixed pattern of motor impairments, which may have been related to early effects of nigral DA neuronal loss or systemic effects associated with MB exposure in addition to PQ. These results indicate that exposure to PQ with or without MB induces neurodegeneration which might occur via an early inflammatory response in young adult animals.
Similar articles
- Temporal effects of paraquat/maneb on microglial activation and dopamine neuronal loss in older rats.
Saint-Pierre M, Tremblay ME, Sik A, Gross RE, Cicchetti F. Saint-Pierre M, et al. J Neurochem. 2006 Aug;98(3):760-72. doi: 10.1111/j.1471-4159.2006.03923.x. J Neurochem. 2006. PMID: 16893418 - Inflammatory priming of the substantia nigra influences the impact of later paraquat exposure: Neuroimmune sensitization of neurodegeneration.
Mangano EN, Hayley S. Mangano EN, et al. Neurobiol Aging. 2009 Sep;30(9):1361-78. doi: 10.1016/j.neurobiolaging.2007.11.020. Epub 2008 Jan 10. Neurobiol Aging. 2009. PMID: 18187236 - Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration.
Purisai MG, McCormack AL, Cumine S, Li J, Isla MZ, Di Monte DA. Purisai MG, et al. Neurobiol Dis. 2007 Feb;25(2):392-400. doi: 10.1016/j.nbd.2006.10.008. Epub 2006 Dec 12. Neurobiol Dis. 2007. PMID: 17166727 Free PMC article. - Paraquat and maneb induced neurotoxicity.
Thrash B, Uthayathas S, Karuppagounder SS, Suppiramaniam V, Dhanasekaran M. Thrash B, et al. Proc West Pharmacol Soc. 2007;50:31-42. Proc West Pharmacol Soc. 2007. PMID: 18605226 Review. - Neurotoxicant-induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration.
Uversky VN. Uversky VN. Cell Tissue Res. 2004 Oct;318(1):225-41. doi: 10.1007/s00441-004-0937-z. Epub 2004 Jul 16. Cell Tissue Res. 2004. PMID: 15258850 Review.
Cited by
- Neurotoxin-Induced Rodent Models of Parkinson's Disease: Benefits and Drawbacks.
El-Gamal M, Salama M, Collins-Praino LE, Baetu I, Fathalla AM, Soliman AM, Mohamed W, Moustafa AA. El-Gamal M, et al. Neurotox Res. 2021 Jun;39(3):897-923. doi: 10.1007/s12640-021-00356-8. Epub 2021 Mar 25. Neurotox Res. 2021. PMID: 33765237 Review. - Environmental Exposures and Parkinson's Disease.
Nandipati S, Litvan I. Nandipati S, et al. Int J Environ Res Public Health. 2016 Sep 3;13(9):881. doi: 10.3390/ijerph13090881. Int J Environ Res Public Health. 2016. PMID: 27598189 Free PMC article. Review. - Coenzyme Q10 effects in neurological diseases.
Rauchová H. Rauchová H. Physiol Res. 2021 Dec 30;70(Suppl4):S683-S714. doi: 10.33549/physiolres.934712. Physiol Res. 2021. PMID: 35199552 Free PMC article. Review. - Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease.
Sikorska M, Lanthier P, Miller H, Beyers M, Sodja C, Zurakowski B, Gangaraju S, Pandey S, Sandhu JK. Sikorska M, et al. Neurobiol Aging. 2014 Oct;35(10):2329-46. doi: 10.1016/j.neurobiolaging.2014.03.032. Epub 2014 Apr 2. Neurobiol Aging. 2014. PMID: 24775711 Free PMC article. - Rat Models of Vocal Deficits in Parkinson's Disease.
Krasko MN, Hoffmeister JD, Schaen-Heacock NE, Welsch JM, Kelm-Nelson CA, Ciucci MR. Krasko MN, et al. Brain Sci. 2021 Jul 13;11(7):925. doi: 10.3390/brainsci11070925. Brain Sci. 2021. PMID: 34356159 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous